ORIGINAL ARTICLE

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas

Socorro María Rodríguez-Pinilla¹, David Sarrió¹, Emiliano Honrado², Gema Moreno-Bueno¹, David Hardisson³, Francisco Calero⁴, Javier Benítez² and José Palacios¹

¹ Laboratory of Breast and Gynaecological Cancer, Molecular Pathology Programme, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
² Department of Human Genetics, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain
³ Pathology Department, Hospital Universitario La Paz, Madrid, Spain
⁴ Department of Gynaecology and Obstetrics, Hospital Universitario La Paz, Madrid, Spain

Correspondence to:
Correspondence to:
Dr José Palacios
Servicio de Anatomía Patológica, Hospital Virgen del Rocío, Avda Manuel Siurot, s/n 43013 Sevilla, Spain; jpalacios{at}cnio.es

Aims: To determine whether basal-like phenotype and vimentin and/or laminin are related in both sporadic/familial (BRCA1 or BRCA2 mutated) tumours.

Methods: 230 non-familial and 28 hereditary node-negative invasive breast carcinomas were immunohistochemically analysed for oestrogen receptors (ER), progesterone receptors (PR), cytokeratin 5/6 (CK5/6), epidermal growth factor receptors (EGFR), Ki67, p53, vimentin and laminin, using tissue microarrays. Tumours were considered to have basal-like phenotype if they were ER negative and HER2 negative, but positive for CK5/6 and/or EGFR.

Results: In sporadic tumours, vimentin expression was found in 77.8% cases with basal-like phenotype and 15.5% of non-basal cases (p<0.001). In familial cases, vimentin was expressed in 83.3% basal-like cancers and 16.7% of non-basal tumours (p<0.001). Vimentin expression was more frequent in BRCA1 than BRCA2 mutation carriers. Vimentin expressing tumours were associated with poor prognosis (p = 0.012) among patients not receiving adjuvant chemotherapy and showed a trend for local recurrence or visceral but not bone metastasis (p = 0.021). Laminin expression was also related to basal-like phenotype in both sporadic/familial cases (p<0.001 and p = 0.007, respectively), but neither with prognosis nor recurrence pattern in sporadic cancers.

Conclusions: Vimentin and laminin expression is associated with basal-like phenotype in breast cancer. Expression of vimentin and laminin is characteristic of BRCA1 associated tumours. Since vimentin and laminin staining is widely used by pathologists for diagnostic purposes, thus demonstrating the robustness of their specific antibodies, the immunohistochemical evaluation of these two molecules could be used in identification of basal-like breast tumours in both sporadic/familial cases.

Abbreviations: EGFR, epidermal growth factor receptor; ER, oestrogen receptor; PR, progesterone receptor

Keywords: vimentin; laminin; basal-like phenotype; node-negative breast carcinomas; immunohistochemistry

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Tan, D S P, Marchio, C, Reis-Filho, J S (2008). Hereditary breast cancer: from molecular pathology to tailored therapies. J. Clin. Pathol. 61: 1073-1082 [Abstract] [Full Text]  
• Rakha, E. A., Reis-Filho, J. S., Ellis, I. O. (2008). Basal-Like Breast Cancer: A Critical Review. JCO 26: 2568-2581 [Abstract] [Full Text]  
• Spurdle, A. B., Lakhani, S. R., Healey, S., Parry, S., Da Silva, L. M., Brinkworth, R., Hopper, J. L., Brown, M. A., Babikyan, D., Chenevix-Trench, G., Tavtigian, S. V., Goldgar, D. E. (2008). Clinical Classification of BRCA1 and BRCA2 DNA Sequence Variants: The Value of Cytokeratin Profiles and Evolutionary Analysis--A Report From the kConFab Investigators. JCO 26: 1657-1663 [Abstract] [Full Text]  
• Dourdin, N., Schade, B., Lesurf, R., Hallett, M., Munn, R. J., Cardiff, R. D., Muller, W. J. (2008). Phosphatase and Tensin Homologue Deleted on Chromosome 10 Deficiency Accelerates Tumor Induction in a Mouse Model of ErbB-2 Mammary Tumorigenesis. Cancer Res. 68: 2122-2131 [Abstract] [Full Text]  
• Sarrio, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., Palacios, J. (2008). Epithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype. Cancer Res. 68: 989-997 [Abstract] [Full Text]